KILITCH DRUGS Share Price

KILITCH DRUGS Share Price

NSE: KILITCH
|
Pharmaceuticals
|
S Cap
₹ 170.90
-₹0.47 (-0.27%)
1D
Last updated 03 Sep, 2026, 09:45 IST

KILITCH DRUGS Share Price Today

As of 3 Sep 2026, KILITCH DRUGS share price is ₹170.90. The stock opened at ₹167.00, compared to its previous close of ₹171.37. During today's trading session, KILITCH DRUGS share price moved in the range of ₹167.00 to ₹173.58, with an average price of ₹170.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹117.25 and a high of ₹219.50. On the performance front, KILITCH DRUGS share price has increased by 8.00% over the last six months and is down 2.63% on a year-on-year basis.

₹167.00
0.27% down today
₹173.58
1D LOW
1D HIGH

KILITCH DRUGS Returns Calculator

Circuit
L
H
₹162.81
₹179.93
52-week
L
H
₹117.25
₹219.50

About KILITCH DRUGS

KILITCH DRUGS Share Price
ISIN
INE729D01010
Sector Market Cap
₹ 599.24 Cr

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.

KILITCH DRUGS Financial Highlights

  • Revenue: KILITCH DRUGS reported revenue of ₹246.71 crore in FY26 vs ₹209.48 crore in FY25. It showed an increase of 17.77% on a yearly basis.
  • Operating Profit: KILITCH DRUGS reported an operating profit of ₹38.65 crore in FY26 vs ₹34.47 crore in FY25. It showed an increase of 12.13% on a year-on-year basis.
  • Net Profit: KILITCH DRUGS reported a net profit of ₹29.50 crore in FY26 vs ₹24.94 crore in FY25. It showed an increase of 18.28% on a yearly basis.

KILITCH DRUGS Quarterly Result Highlights

  • KILITCH DRUGS reported revenue of ₹47.78 crore in Jun 2026, compared with ₹90.09 crore in Mar 2026, representing a decrease of 46.96% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported an operating profit of ₹3.86 crore in Jun 2026, compared with ₹20.21 crore in Mar 2026, representing a decrease of 80.90% on a quarter-on-quarter (QoQ) basis.
  • KILITCH DRUGS reported a profit of ₹1.97 crore in Jun 2026, compared with ₹14.88 crore in Mar 2026, reflecting a decrease of 86.76% on a QoQ basis.
  • The earnings per share (EPS) of KILITCH DRUGS stood at ₹8.91 during Jun 2026.
Know more
Promoters
63.77%
FII
0.12%
Other DII
0.00%
Retail and other
36.11%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.12%
Mkt Cap Cr
599.24
P/E
20.53
P/B
2.14
ROE
10.79%
D/E
0.27
ROCE
12.00%
Div. Yield
0.00%
EPS(TTM)
9.57
Turnover
0.39
EV/EBITDA
13.96
Net Margin
17.18%
Op. Margin
24.94%
ROA
6.38%
Quick Ratio
1.82
Curr. Ratio
2.66
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Kilitch Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Kilitch Drugs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Kilitch Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

KILITCH DRUGS Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹235.47₹198.32₹154.37₹139.60
Other Income₹11.24₹11.16₹4.48₹2.92
Total Revenue₹246.71₹209.48₹158.85₹142.52
Total Expenses₹208.06₹175.00₹139.50₹130.50
Profit Before Tax₹38.65₹34.47₹19.35₹12.01
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹29.50₹24.94₹13.58₹8.28
EPS - Basic₹8.91₹16.60₹9.17₹6.71
EPS - Diluted₹8.91₹16.60₹9.17₹6.71

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.65₹34.47₹19.35₹12.01
Income before WC changes₹46.60₹35.64₹29.81₹21.80
Change in Assets-₹40.99-₹38.42-₹12.08-₹13.19
Change in Liabilities₹28.89₹28.80-₹12.23-₹1.70
Change in WC-₹12.11-₹9.63-₹24.31-₹14.88
Cash flow from Operations₹23.96₹17.54-₹1.53₹2.59
Cash flow from Investing-₹100.44-₹39.95-₹8.16₹7.92
Cash flow from Financing₹82.45₹13.24₹8.81-₹0.72
Total Cash Flow₹5.97-₹9.16-₹0.88₹9.78
Cash (Start of the year)₹9.80₹18.96₹19.85₹10.06
Cash (End of the year)₹15.77₹9.80₹18.96₹19.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹235.55₹138.87₹94.07₹93.12
Current Assets₹222.20₹173.92₹145.99₹126.40
Total Assets₹457.75₹312.78₹240.06₹219.52
Current Liabilities₹121.60₹84.31₹64.22₹68.87
Net Current Asset₹100.60₹89.61₹81.78₹57.53
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹276.87₹200.46₹175.67₹150.58
Total Equity & Liabilities₹457.75₹312.78₹240.06₹219.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹188.57₹181.59₹131.60₹117.78
Other Income₹13.85₹13.72₹6.19₹4.60
Total Revenue₹202.42₹195.30₹137.79₹122.38
Total Expenses₹160.87₹154.61₹114.43₹102.93
Profit Before Tax₹41.55₹40.69₹23.35₹19.45
Tax₹9.15₹9.53₹5.78₹3.73
Profit After Tax₹32.40₹31.16₹17.57₹15.72
EPS - Basic₹9.57₹19.37₹11.03₹10.09
EPS - Diluted₹9.57₹19.37₹11.03₹10.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹41.55₹40.69₹23.35₹19.45
Income before WC changes₹42.44₹35.00₹25.22₹21.40
Change in Assets-₹41.14-₹32.83-₹18.15-₹12.35
Change in Liabilities₹21.56₹21.53-₹2.61₹1.37
Change in WC-₹19.58-₹11.30-₹20.76-₹10.97
Cash flow from Operations₹12.32₹15.23-₹2.58₹6.10
Cash flow from Investing-₹96.00-₹41.42-₹8.71₹6.24
Cash flow from Financing₹85.57₹15.65₹11.40₹3.04
Total Cash Flow₹1.89-₹10.54₹0.11₹15.39
Cash (Start of the year)₹7.41₹17.95₹17.84₹2.45
Cash (End of the year)₹9.30₹7.41₹17.95₹17.84

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹293.31₹195.78₹145.98₹137.65
Current Assets₹206.14₹162.38₹141.49₹114.77
Total Assets₹499.46₹358.16₹287.47₹252.42
Current Liabilities₹107.17₹77.20₹64.37₹56.42
Net Current Asset₹98.98₹85.18₹77.11₹58.35
Non-Current Liabilities₹59.28₹28.02₹0.17₹0.07
Equity Capital₹333.01₹252.94₹222.92₹195.93
Total Equity & Liabilities₹499.46₹358.16₹287.47₹252.42
* All values are in INR Crore
Qty
Bid
2
170.85
6
169.5
50
169.2
100
168.11
10
168.1
Ask
Qty
170.9
2
170.95
178
171.85
270
172
200
173.53
95
Bid Total: 168
Ask Total: 745
Buy orders: 18%
Sell orders: 82%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.14
Neutral
ATR (14)
7.55
Neutral
STOCH(9,6)
63.7
Neutral
STOCH RSI (14)
84.49
Bearish
ADX(9)
21.7
Bearish
UO(9)
53.71
Neutral
ROC(12)
-0.7
Bearish
WillR(14)
-40.1
Neutral
Period
Simple value
Exponential vaue
5D
171.93
171.4
10D
169.37
171.69
20D
176.09
174.39
50D
181.85
177.47
100D
173.66
175.31
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
KILITCH DRUGS Share Price
KILITCH DRUGS
Pharmaceuticals
Add Stock
Add Another

KILITCH DRUGS Share Price FAQs